The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Eisai
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck; Takeda
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst)
 
Rosine Guimbaud
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; SERVIER
Travel, Accommodations, Expenses - BMS
 
Ian Chau
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Incyte; Lilly; Merck Serono; MSD Oncology; OncXerna Therapeutics; Pierre Fabre; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck Serono; MSD
 
Marc Van Den Eynde
Consulting or Advisory Role - amgen (Inst); Lilly (Inst); Merck KGaA (Inst); SERVIER (Inst)
Research Funding - Merck KGaA (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Roche (Inst)
 
Joan Maurel
Consulting or Advisory Role - Advance Medical; Amgen; AstraZeneca; Bayer; Biocartis; Cancer Expert Now; Fundación Clínica Universitaria; Incyte; Merck; NanoString Technologies; Pierre Fabre; Roche; Sanofi; SERVIER; Shire; Sirtex Medical
Research Funding - Carlos III Health Institute; Catalan Agency for Management of University and Research Grants; Fundació la Marató de TV3; Olga Torres Foundation
 
Jeanne Tie
Honoraria - Amgen; FivepHusion; Inivata; Merck Serono; SERVIER
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; Pierre Fabre
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - AstraZeneca (Inst); Sanofi (Inst)
 
Kun-Huei Yeh
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Ono Pharmaceutical; Takeda
 
Daniel Barrios
Employment - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Kojiro Kobayashi
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Emarjola Bako
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Mehreteab Aregay
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Gerold Meinhardt
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Bayer; Daiichi Sankyo
 
Salvatore Siena
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; CheckmAb; Clovis Oncology; Daiichi Sankyo; Incyte; Merck; Novartis; Roche/Genentech; Seagen
Research Funding - MSD Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche